Trial document
DRKS00022339
Trial Description
Title
Burden of disease of people with dementia in nursing homes measured by IPOS-Dem: a stepped-wedge cluster randomised controlled trial
Trial Acronym
IPOS-Dem
URL of the Trial
https://www.heds-fr.ch/media/2272/fiche_projet_ako_ipos-dem.pdf
Brief Summary in Lay Language
In this study, we check the IPOS-Dem instrument for its validity (1). Also, we check if there is a long-term effect on the burden of disease when using the IPOS-Dem Instrument in nursing homes. IPOS-Dem should be capable of recognising and prioritising all Symptoms and Needs of people with dementia. Highlighting those symptoms and needs helps to reduce the burden of disease. As far as we know, this is the first study into long-term effects of such a needs and symptom assessment for people with dementia in nursing homes.
GOALS:
*To reduce the burden of disease in people with dementia.
*To help the family frequently tell their understanding in an orderly way to nursing home staff.
*To improve the display of value and results from nursing care.
METHODS:
We include people with dementia, nursing staff of all qualification levels and family members. The study contains two interventions. All nursing homes will receive both interventions. Nurses and family members learn to use IPOS-Dem in the first intervention. During the second intervention, the staff gets coached in symptom management. The interventions inside the nursing homes last 17 months.
BACKGROUND:
People with dementia often suffer from more than one disease and symptoms. Often the symptoms and illnesses are not well treated. In turn, this leads to unnecessary suffering and stress, lowering the quality of life for people with dementia. Diversity among people with dementia and cognitive manifestations (e.g. impaired memory or communication) may lead to misinterpretation or dismissal of needs and symptoms. While swiss nursing homes use routine assessments like RAI or BESA for regular examination, documentation and tariff, only authorised nurses may utilise them. Validated holistic assessment instruments (e.g. IPOS-Dem) may support staff and family to reveal the needs of people with dementia.
Brief Summary in Scientific Language
This study will be conducted as a stepped wedge design (SW-CRT), involving two complex interventions for people with dementia in nursing homes. 13 nursing homes will be randomized in three steps. In three monthly intervals, 4-5 nursing homes will switch from the intervention 1 to the intervention 2 at given periods until all nursing homes are applying the intervention.
The study will train family members and nurses in nursing homes in their symptom assessment based on an instrument which is called IPOS-Dem (Integrated Palliative care Outcome Scale for Dementia). The training will include systematic observation training in assessing unmet needs of people with dementia (complex intervention no 1). Nurses will be also trained in symptom management (complex intervention no 2).
Do you plan to share individual participant data with other researchers?
Yes
Description IPD sharing plan:
Dataset: Expected mid 2022, indexed and for download on https://zenodo.org/ (eventually embargoed, dependant on publisher)
Organizational Data
- DRKS00022339
- 2020/10/05
- [---]*
- yes
- Approved
- 2019-01847, Kantonale Ethikkommission Zürich Stampfenbachstrasse 121 Postfach 8090 Zürich
Secondary IDs
- U1111-1254-4246
- SNCTP000003941 (SNTCP)
- 2019-01847 (BASEC-ID)
Health Condition or Problem studied
- Dementia, Alzheimer
- F00 - Dementia in Alzheimer disease
- F01 - Vascular dementia
- F02 - Dementia in other diseases classified elsewhere
- F03 - Unspecified dementia
Interventions/Observational Groups
- The study will train family members and nurses in nursing homes in their symptom assessment based on an instrument which is called IPOS-Dem (Integrated Palliative care Outcome Scale for Dementia). The training will include systematic observation training in assessing unmet needs of people with dementia (complex intervention no 1).
- Nurses will be also trained in symptom management (complex intervention no 2).
Characteristics
- Interventional
- [---]*
- Other
- Open (masking not used)
- [---]*
- Other
- Supportive care
- Crossover
- N/A
- No
Primary Outcome
Burden of disease (BOD):
The primary endpoint of this study is the reduction of burden of disease (BOD), measured with the total IPOS-Dem score (sum-score) in PwD compared to before and after the interventions. The primary endpoint will be assessed with the clinically relevant difference of 8 between baseline, and month 1-17.
Secondary Outcome
The secondary endpoint of this study is the improvement (= significant improvement of p<0.05) of Quality of life in PwD measured with the QUALIDEM outcome measure. The QUALIDEM will be measured every three months for 17 months. Longitudinal, total domain scores for PwD will be calculated and illustrated to demonstrate the quality of life trajectory.
Countries of Recruitment
- Switzerland
Locations of Recruitment
- other
- other
- other
- other
- other
- other
- other
- other
- other
- other
Recruitment
- Actual
- 2020/10/01
- 260
- Multicenter trial
- National
Inclusion Criteria
- Both, male and female
- no minimum age
- no maximum age
Additional Inclusion Criteria
(1) Nursing Homes (NH): at least 8 People with dementia (PWD), use BESA or RAI for Routine Assessment; (2) PWD: Diagnosed with Alzheimers' disease or vascular dementia OR Symptoms of Dementia documented in NH Records.; (3) Nursing Staff: At least 18 years old, employed in respective NH for at least three months with a quota equivalent to at least 20% (= working one day per week), speak german; (4) Relative: family member OR legal guardian of PWD fullfilling criteria listed above (2)
Exclusion Criteria
(1) PwD, who are hospitalised during the recruitment phase and therefore not physically in the nursing home at the time of study start; (2) Relative: family member OR legal guardian of PWD fullfilling criteria listed above (1)
Addresses
-
start of 1:1-Block address primary-sponsor
- Heds FR, School of Health Professions
- Ms. Professor Andrea Luise Koppitz
- Route des Arsenaux 16a
- 1700 Freiburg
- Switzerland
end of 1:1-Block address primary-sponsorstart of 1:1-Block address contact primary-sponsor- +41 26 429 60 44
- [---]*
- andrea.koppitz at hefr.ch
- https://www.heds-fr.ch/de/forschung/forschungsbereiche/altern/
end of 1:1-Block address contact primary-sponsor -
start of 1:1-Block address other
- Heds FR, School of Health Professions
- Mr. Frank Spichiger
- Route des Arsenaux 16a
- 1700 Freiburg CH
- Switzerland
end of 1:1-Block address otherstart of 1:1-Block address contact other- +41 26 429 60 86
- [---]*
- frank.spichiger at hefr.ch
- [---]*
end of 1:1-Block address contact other -
start of 1:1-Block address scientific-contact
- Heds FR, School of Health Professions
- Ms. Professor Andrea Luise Koppitz
- Route des Arsenaux 16a
- 1700 Freiburg
- Switzerland
end of 1:1-Block address scientific-contactstart of 1:1-Block address contact scientific-contact- +41 26 429 60 44
- [---]*
- andrea.koppitz at hefr.ch
- https://www.heds-fr.ch/de/forschung/forschungsbereiche/altern/
end of 1:1-Block address contact scientific-contact -
start of 1:1-Block address public-contact
- Heds FR, School of Health Professions
- Ms. Professor Andrea Luise Koppitz
- Route des Arsenaux 16a
- 1700 Freiburg
- Switzerland
end of 1:1-Block address public-contactstart of 1:1-Block address contact public-contact- +41 26 429 60 44
- [---]*
- andrea.koppitz at hefr.ch
- https://www.heds-fr.ch/de/forschung/forschungsbereiche/altern/
end of 1:1-Block address contact public-contact
Sources of Monetary or Material Support
-
start of 1:1-Block address materialSupport
- Schweizerische Akademie der Medizinischen Wissenschaften
- Haus der Akademien, Laupenstrasse 7
- 3001 Bern
- Switzerland
end of 1:1-Block address materialSupportstart of 1:1-Block address contact materialSupport- +41 311 306 92 70
- [---]*
- mail at samw.ch
- https://www.samw.ch
end of 1:1-Block address contact materialSupport -
start of 1:1-Block address otherSupport
- Gottfried und Julia Bangerter-Rhyner-Stiftung
- Lange Gasse 15, Postfach
- 4002 Basel
- Switzerland
end of 1:1-Block address otherSupportstart of 1:1-Block address contact otherSupport- +41 61 277 01 22
- [---]*
- info at bangerter-stiftung.ch
- http://www.bangerter-stiftung.ch/bangerter/de/stiftung/portrait.html
end of 1:1-Block address contact otherSupport
Status
- Recruiting ongoing
- [---]*
Trial Publications, Results and other Documents
- [---]*